ğŸ§¬ GENE OF THE WEEK: DRD2

The reward pathway gene. DRD2 variants affect dopamine signaling, influencing addiction risk, reward sensitivity, and impulsive behavior.

DRD2 (Dopamine Receptor D2) is central to the brain's reward system. Variants affect receptor density and function.

Normal DRD2 Density:
âœ… Adequate dopamine signaling
âœ… Normal reward response
âœ… Lower addiction risk
âœ… Standard impulse control
âœ… Typical motivation

Reduced DRD2 (A1 allele):
âš ï¸ 30-40% fewer D2 receptors
âš ï¸ Blunted reward response
âš ï¸ Higher addiction risk
âš ï¸ Seek more stimulation
âš ï¸ "Reward Deficiency Syndrome"

Clinical Implications:

A1 allele carriers need more stimulation to feel "normal"â€”leading to increased risk of:
â†’ Alcohol use disorder
â†’ Drug addiction
â†’ Food addiction/obesity
â†’ Gambling
â†’ Compulsive behaviors

Understanding Your Risk:

Genetic knowledge enables personalized prevention:
â†’ Higher awareness of addiction vulnerability
â†’ Avoid recreational substance use
â†’ Find healthy dopamine sources (exercise, achievement)
â†’ Consider this in pain management decisions

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #DRD2 #Dopamine #Addiction #Reward #Bioscope
